Detailed Narrative
Robust Financial Performance and Core MCC Business Growth
Sigachi Industries delivered strong financial results for Q4 FY25 and the full fiscal year. FY25 total operating income grew 25.42% to INR 500 crores, with EBITDA expanding 46.21% to INR 112 crores, achieving a margin of 22.38%. The core Microcrystalline Cellulose (MCC) business was a primary driver, with FY25 revenue increasing 35.75% to INR 409 crores and volumes up 29.57%, supported by robust demand in both domestic and international markets. The company aims to sustain revenue growth exceeding 25% over the next 2-3 years and achieve EBITDA margins beyond 25%.
Strategic Capacity Expansion and Product Mix Optimization
The company's newly commissioned 7,000 metric ton per annum MCC plant is currently operating at 68% utilization and is targeted to reach full capacity by FY26. This will be achieved through debottlenecking and small capex additions, allowing capacity to increase up to 25,000 MTPA without major new plant investments. Sigachi is also focusing on improving its sales mix by prioritizing special grade products and co-processed excipients, which offer higher margins, contributing to both revenue and margin expansion.
Diversification into API and O&M Services
Sigachi is actively diversifying its revenue streams through its API and Operations & Maintenance (O&M) segments. The API arm, Trimax, acquired in August 2023, saw FY25 revenue of INR 29 crores, a strategic shift from FY24's INR 57 crores to focus on higher-margin products and regulated markets. The company has secured CEP certification for Metformin HCL, enabling entry into Europe, and plans to file 5 more CEPs in CY25. The O&M service business is projected to grow significantly, targeting INR 75 crores in FY26 from INR 41 crores in FY25, with new client additions like Adani Solar.
New Growth Avenues: CCS Plant and Enhanced R&D
The company is advancing its Cellulose Compaction System (CCS) project, having secured environmental clearance for its facility at Dahej-2 SEZ. Commercialization of this INR 90 crore plant is targeted for October 2026, with INR 40-50 crores expected to be spent in the current fiscal year and INR 55-60 crores funded through debt. This project is anticipated to achieve an asset turnover of 3-4x within 2-3 years post-commissioning. Furthermore, Sigachi has established a state-of-the-art R&D center in Hyderabad to accelerate API development, analytical research, and product innovation.
Capital Allocation and Shareholder Value Focus
Management's capital allocation strategy supports its growth trajectory, with planned capex for the CCS project and ongoing debottlenecking for MCC. While promoter pledging increased to 44% to fund preferential equity shares for company investment, management confirmed the proceeds were utilized for the company and that they have the ability to reduce the pledging. The company remains committed to operational excellence, strengthening its core businesses, and delivering long-term value to stakeholders.